RetractedArticleMedical science monitor : international medical journal of experimental and clinical research2018

The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.

Hao Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.